The inhibition of the CCL2–CCR2 complex or CCL2 or CCR2 alone, has provided a lowering in tumor growth and prolonged survival in some cancers, giving another opportunity to evaluate a new cancer treatment [114,115]. The gene discussed is CCR2; the disease is neoplasm.